CING
Price
$3.90
Change
+$0.11 (+2.90%)
Updated
Sep 5 closing price
Capitalization
21.11M
LQDA
Price
$28.85
Change
+$0.01 (+0.03%)
Updated
Sep 5 closing price
Capitalization
2.48B
66 days until earnings call
Interact to see
Advertisement

CING vs LQDA

Header iconCING vs LQDA Comparison
Open Charts CING vs LQDABanner chart's image
Cingulate
Price$3.90
Change+$0.11 (+2.90%)
Volume$147.07K
Capitalization21.11M
Liquidia
Price$28.85
Change+$0.01 (+0.03%)
Volume$1.41M
Capitalization2.48B
CING vs LQDA Comparison Chart in %
Loading...
CING
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CING vs. LQDA commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CING is a StrongBuy and LQDA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CING: $3.90 vs. LQDA: $28.85)
Brand notoriety: CING and LQDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CING: 105% vs. LQDA: 52%
Market capitalization -- CING: $21.11M vs. LQDA: $2.48B
CING [@Biotechnology] is valued at $21.11M. LQDA’s [@Biotechnology] market capitalization is $2.48B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CING’s FA Score shows that 0 FA rating(s) are green whileLQDA’s FA Score has 1 green FA rating(s).

  • CING’s FA Score: 0 green, 5 red.
  • LQDA’s FA Score: 1 green, 4 red.
According to our system of comparison, LQDA is a better buy in the long-term than CING.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CING’s TA Score shows that 4 TA indicator(s) are bullish while LQDA’s TA Score has 3 bullish TA indicator(s).

  • CING’s TA Score: 4 bullish, 6 bearish.
  • LQDA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both CING and LQDA are a bad buy in the short-term.

Price Growth

CING (@Biotechnology) experienced а -2.26% price change this week, while LQDA (@Biotechnology) price change was +4.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

LQDA is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LQDA($2.48B) has a higher market cap than CING($21.1M). LQDA YTD gains are higher at: 145.323 vs. CING (-20.892). CING has higher annual earnings (EBITDA): -15.75M vs. LQDA (-133.4M). LQDA has more cash in the bank: 173M vs. CING (9.52M). CING has less debt than LQDA: CING (5.08M) vs LQDA (200M). LQDA has higher revenues than CING: LQDA (19.3M) vs CING (0).
CINGLQDACING / LQDA
Capitalization21.1M2.48B1%
EBITDA-15.75M-133.4M12%
Gain YTD-20.892145.323-14%
P/E Ratio0.03N/A-
Revenue019.3M-
Total Cash9.52M173M6%
Total Debt5.08M200M3%
FUNDAMENTALS RATINGS
LQDA: Fundamental Ratings
LQDA
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
11
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CINGLQDA
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 26 days ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 12 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CING
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MINHX44.500.24
+0.54%
MFS International Intrinsic Value R4
LSWWX26.590.03
+0.11%
Loomis Sayles Global Allocation Y
CDOFX49.50N/A
N/A
Crawford Small Cap Dividend
PFGEX29.12N/A
N/A
Parnassus Growth Equity Investor
PSKCX44.98N/A
N/A
Virtus KAR Mid-Cap Growth C

CING and

Correlation & Price change

A.I.dvisor indicates that over the last year, CING has been loosely correlated with ABCL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CING jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CING
1D Price
Change %
CING100%
+2.90%
ABCL - CING
34%
Loosely correlated
+1.44%
XRTX - CING
28%
Poorly correlated
+1.85%
BEIGF - CING
28%
Poorly correlated
N/A
LQDA - CING
26%
Poorly correlated
+0.03%
BIXT - CING
26%
Poorly correlated
+1.36%
More

LQDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LQDA has been loosely correlated with MTVA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if LQDA jumps, then MTVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LQDA
1D Price
Change %
LQDA100%
+0.03%
MTVA - LQDA
44%
Loosely correlated
+0.44%
DMAC - LQDA
33%
Poorly correlated
+14.34%
TPST - LQDA
32%
Poorly correlated
+9.57%
XNCR - LQDA
32%
Poorly correlated
+2.15%
ROIV - LQDA
32%
Poorly correlated
+2.78%
More